10-Hydroxy-2-decenoic acid (10-HDA) is a medium-chain α,β-unsaturated carboxylic acid that exists in royal jelly with terminal hydroxylation. It has a broad market value because of its antibacterial, anti-inflammatory, anti-tumor, anti-radiation, and ...
Ziting Xu +11 more
doaj +1 more source
Polycystic ovarian syndrome (PCOS) is the most principal reason for infertility in reproductive women, but no versatile treatment is feasible. Although trans-10-hydroxy-2-decenoic acid (10H2DA) exhibits the anti-inflammatory, anti-cancerous and ...
Jicheng Huang +6 more
doaj +1 more source
Male sex, early life chemical exposure and the brain aromatase enzyme have been implicated in autism spectrum disorder (ASD). In the Barwon Infant Study birth cohort (n = 1074), higher prenatal maternal bisphenol A (BPA) levels are associated with higher
Christos Symeonides +36 more
doaj +1 more source
The key royal jelly component 10-hydroxy-2-decenoic acid protects against bone loss by inhibiting NF-κB signaling downstream of FFAR4. [PDF]
Tsuchiya Y +6 more
europepmc +1 more source
10-Hydroxy-2-decenoic Acid Attenuates Colitis-Associated Cognitive Dysfunction via IFITM3-Related Gut-Brain Axis Inflammation. [PDF]
Huang S +5 more
europepmc +1 more source
Determination of 10-Hydroxy-2-decenoic Acid in Royal Jelly by High Performance Liquid Chromatography
SHIZUO NAKAJIN +3 more
openaire +2 more sources
10-Hydroxy-2-decenoic acid, a natural product, improves hyperglycemia and insulin resistance in obese/diabetic KK-Ay mice, but does not prevent obesity. [PDF]
Watadani R +5 more
europepmc +1 more source
161 Interest of 10-Hydroxy-2-decenoic acid and acefylline-containing-creams for hydration and nutrition of dry skin [PDF]
M. Galliano +4 more
openaire +1 more source
10-Hydroxy-2-decenoic Acid, the Major Lipid Component of Royal Jelly, Extends the Lifespan of Caenorhabditis elegans through Dietary Restriction and Target of Rapamycin Signaling. [PDF]
Honda Y +6 more
europepmc +1 more source
Pharmaceutical and Therapeutic Applications of Royal Jelly for Ocular Surface Diseases: A Comprehensive Review. [PDF]
Mortazavi M +3 more
europepmc +1 more source

